CXL20023008 | 盐酸依匹斯汀 | epinastine hydrochloride | Active ingredient | Chemical Drugs(4) | New Drug Application | 2003-10-30 | 广西壮族自治区桂林制药厂 | Guilin Pharmaceutical Co Ltd | Certificate Issued | 2004-04-02 | view |
CYHS1100323 | 盐酸依匹斯汀 | epinastine hydrochloride | Active ingredient | Chemical Drugs(6) | Generic Drug | 2011-08-08 | 四川科瑞德凯华制药有限公司 | Luzhou Credit Pharmaceutical Co Ltd | Certificate Issued | 2016-09-11 | view |
CXL20020106 | 盐酸依匹斯汀 | epinastine hydrochloride | Active ingredient | Chemical Drugs(4) | New Drug Application | 2002-02-26 | 重庆普惠药物科技发展有限公司 | Chongqing Pratt & Whitney Pharmaceutical Technology Development Co Ltd | Pending Approval | 2002-11-05 | view |
JTH1900190 | 盐酸依匹斯汀 | epinastine hydrochloride | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2019-07-09 | ICROM S.P.A. | Icrom SpA | Certificate Issued | 2019-08-12 | view |
X0401970 | 盐酸依匹斯汀 | epinastine hydrochloride | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2004-04-19 | 苏州万庆药业有限公司 | Sinopharm Zhijun (Suzhou) Pharmaceutical Co Ltd | Certificate Issued | 2004-12-10 | view |
CXHS1090002 | 盐酸依匹斯汀 | epinastine hydrochloride | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2010-12-20 | 苏州万庆药业有限公司 | Sinopharm Zhijun (Suzhou) Pharmaceutical Co Ltd | In Review | 2004-04-15 | view |
JTH1800385 | 盐酸依匹斯汀 | epinastine hydrochloride | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2018-10-22 | ICROM S.P.A. | Icrom SpA | Certificate Issued | 2018-11-23 | view |
H20020243 | 盐酸依匹斯汀 | epinastine hydrochloride | Active ingredient | Chemical Drugs | Import Drug Application | 2002-09-28 | 勃林格殷格翰公司北京办事处 | Boehringer Ingelheim Shanghai Pharmaceuticals Co Ltd Beijing | Approval Completed-Pending Certificated | | view |
CYHR1600041 | 盐酸依匹斯汀 | epinastine hydrochloride | Active ingredient | Chemical Drugs | State Standards | 2017-03-15 | 四川科瑞德凯华制药有限公司 | Luzhou Credit Pharmaceutical Co Ltd | Certificate Issued | 2017-08-14 | view |
X0400072 | 盐酸依匹斯汀 | epinastine hydrochloride | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2004-01-10 | 重庆凯林制药有限公司 | Chongqing Carelife Pharmaceutical Co Ltd | Certificate Issued | 2004-10-12 | view |
CXHL0600033 | 盐酸依匹斯汀分散片 | epinastine hydrochloride | Tablet | Chemical Drugs(5) | New Drug Application | 2006-03-02 | 四川科瑞德制药有限公司 | Sichuan Credit Pharmaceutical Co Ltd | Certificate Issued | 2007-10-18 | view |
CXHR0900260 | 盐酸依匹斯汀分散片 | epinastine hydrochloride | Tablet | Chemical Drugs | State Standards | 2009-12-30 | 四川科瑞德制药有限公司 | Sichuan Credit Pharmaceutical Co Ltd | Certificate Issued | 2011-01-07 | view |
CXHS0800273 | 盐酸依匹斯汀分散片 | epinastine hydrochloride | Tablet | Chemical Drugs(5) | New Drug Application | 2008-12-26 | 四川科瑞德制药有限公司 | Sichuan Credit Pharmaceutical Co Ltd | Certificate Issued | 2009-10-13 | view |
CXHL1000199 | 盐酸依匹斯汀分散片 | epinastine hydrochloride | Tablet | Chemical Drugs(5) | New Drug Application | 2010-09-15 | 北京朗依制药有限公司 | Beijing Jinchengtaier Pharmaceutical Co Ltd | Certificate Issued | 2012-01-30 | view |
CYHS2100125 | 盐酸依匹斯汀滴眼液 | epinastine hydrochloride | Eye drops | Chemical Drugs(3) | Generic Drug | 2021-01-28 | 兆科(广州)眼科药物有限公司 | Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Limited | Certificate Issued | 2021-11-15 | view |
CYHL2200034 | 盐酸依匹斯汀滴眼液 | epinastine hydrochloride | Eye drops | Chemical Drugs(3) | Generic Drug | 2022-04-21 | | Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Limited | | | view |
CYHL2300013 | 盐酸依匹斯汀滴眼液 | epinastine hydrochloride | Eye drops | Chemical Drugs(3) | Generic Drug | 2023-02-02 | | Runer Ophthalmic Drugs (Guangzhou) Co Ltd | | | view |
CYHL2400174 | 盐酸依匹斯汀滴眼液 | epinastine hydrochloride | Eye drops | Chemical Drugs(3) | Generic Drug | 2024-08-23 | | Baishan Technology (Huzhou) Co Ltd | | | view |
CYHL2200074 | 盐酸依匹斯汀滴眼液 | epinastine hydrochloride | Eye drops | Chemical Drugs(3) | Generic Drug | 2022-08-31 | | Shentian Pharmaceutical (China) Co Ltd | | | view |
CYHS2400929 | 盐酸依匹斯汀滴眼液 | epinastine hydrochloride | Eye drops | Chemical Drugs(3) | Generic Drug | 2024-03-27 | | | | | view |